That quiet fear in the emergency room... "What if next time is worse?"
Most people are told this is simply diabetic peripheral neuropathy progressing.
But progression doesn't happen randomly. Something fuels it. And you may never have been told what.
You were told neuropathy is caused by diabetes. But diabetes may only be the trigger - not the real engine.
Emerging research discussions suggest a specific enzyme may become overactive inside nerve tissue. When this enzyme becomes aggressive, it may begin breaking down myelin - the protective insulation around your nerves.
1
Without insulation, nerve signals misfire and fail.
2
Inflammation rises, creating an even more hostile environment for your nerves.
3
A sticky plaque-like buildup may begin forming around damaged nerves.
4
This internal cascade accelerates - and conventional treatments don't stop it.
"Pain relief was masking the damage. Even when symptoms seemed better, the underlying nerve destruction process continued silently."
- Clinical observation highlighted by Dr. Lewis Clark and Barbara O'Neill
Research on Enzyme-Driven Tissue Degradation in Inflammatory Conditions
Researchers at Harvard Medical School have published findings on enzyme-driven tissue degradation in inflammatory conditions - a mechanism rarely addressed in standard clinical protocols for neuropathy.
Johns Hopkins University
Research on Myelin Breakdown and Nerve Dysfunction
Johns Hopkins researchers have also explored how myelin breakdown contributes to nerve dysfunction - and why glucose control alone is not sufficient to stop this process.
Yet most standard neuropathy treatment plans still focus only on glucose control and pain suppression.
They are not targeting the internal enzyme cascade. And without addressing that engine, symptoms often return.
Clinical and integrative perspectives on nerve recovery
Dr. Lewis Clark and Barbara O'Neill began asking a different question. They discovered that pain relief was not enough, because the real issue was a biochemical erosion happening silently, independent of visible symptoms.
Their ongoing review of patient patterns and inflammatory mechanisms suggests that many protocols only treat discomfort, without addressing what keeps the damage cycle active. Until that internal reaction is slowed, nothing truly changes: symptoms return, damage advances, and the cycle repeats.
"Pain relief was masking the damage. Even when symptoms seemed better, the underlying nerve destruction process continued silently."
- Clinical observation highlighted by Dr. Lewis Clark and Barbara O'Neill
Because blind trust is what keeps most people stuck in ineffective neuropathy treatment cycles.
Watch the short presentation below and decide for yourself.
It explains how eliminating sticky plaque, slowing a specific enzyme reaction, and supporting myelin
may help restore nerves from the inside out.
If the internal destructive enzyme process continues unchecked, damage progresses. But if that cascade is interrupted early, the body may have regenerative capacity.
